DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

Published in:

EMBO Molecular Medicine, 2024, v. 16, n. 7, p. 1603, doi. 10.1038/s44321-024-00088-0

By:

• Momeny, Majid;
• Tienhaara, Mari;
• Sharma, Mukund;
• Chakroborty, Deepankar;
• Varjus, Roosa;
• Takala, Iina;
• Merisaari, Joni;
• Padzik, Artur;
• Vogt, Andreas;
• Paatero, Ilkka;
• Elenius, Klaus;
• Laajala, Teemu D;
• Kurppa, Kari J;
• Westermarck, Jukka

Publication type:

Article